phase readout

NCT06692738: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

RECRUITINGupdated 11h ago

community read0 votes

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 8h ago

Found something off?